mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.007 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.007 |
mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.008 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
0.078 |
0.009 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.01 |
mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.01 |
mRNA |
GW 441756 |
GDSC1000 |
pan-cancer |
AAC |
0.087 |
0.01 |
mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
0.084 |
0.01 |
mRNA |
BMS-536924 |
GDSC1000 |
pan-cancer |
AAC |
0.079 |
0.01 |